Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CVS HEALTH CorpCVS · Entity 2884 | Senior Vice President | August 19, 2009 | August 20, 2009 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CVS HEALTH Corp
Report date August 19, 2009 · Filed August 20, 2009
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 16,021.2799 |
Reported balance
After 2009-08-19 transaction · row 1
1 source rowRow 1 · 2009-08-19 · Sale · Disposed 5,657 · Balance 16,021.2799 F1: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $34.5100 and $34.5200. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust As Beneficiary | 21,677.5396 |
Reported balance
Holding disclosure · report date 2009-08-19 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 21,677.5396 |
| Common Stock (restricted)SEC Table I · non-derivative | Direct | 34,360 |
Reported balance
Holding disclosure · report date 2009-08-19 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 34,360 |
| ESOP Common StockSEC Table I · non-derivative | IndirectBy ESOP | 1,698.5315 |
Reported balance
Holding disclosure · report date 2009-08-19 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 1,698.5315 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $34.5100 and $34.5200.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 08, 2004 Filed Jan 12, 2004 20:13 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 30,000 | $0.00 Strike: $35.34 | $0.00 |
DisclosureSEC source: 0001194416-04-000006 · c0001194412d20040112f4f.xml · derivative · entry 6 FERDINANDI V MICHAEL · CIK 0001194412 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2011-01-08 F1 · derivative.exercise_date: Options become exercisable in three equal annual installments, commencing 01/08/2005. Read SEC document |
| January 08, 2004 Filed Jan 12, 2004 20:13 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (Restricted) | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001194416-04-000006 · c0001194412d20040112f4f.xml · nonDerivative · entry 1 FERDINANDI V MICHAEL · CIK 0001194412 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,256 Read SEC document |
| December 31, 2003 Filed Feb 10, 2004 16:04 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantPhantom Stock Credits · Derivative | 391 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001194405-04-000002 · c0001194412d20040210f5f.xml · derivative · entry 6 FERDINANDI V MICHAEL · CIK 0001194412 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 391 Underlying: Common Stock · 391 shares Expires not disclosed F5 · derivative.exercise_price: Each share credit is equivalent to one share; 1-for-1 conversion. F6 · shares: Reflects 2001, 2002 and 2003 year end company match share credits of 69, 66 and 256, respectively, under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person. F6 · derivative.exercise_date: Reflects 2001, 2002 and 2003 year end company match share credits of 69, 66 and 256, respectively, under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person. F6 · derivative.expiration_date: Reflects 2001, 2002 and 2003 year end company match share credits of 69, 66 and 256, respectively, under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person. Read SEC document |
| May 02, 2003 Filed May 6, 2003 21:47 UTC | CVS HEALTH Corp CVS · Entity 2884 | PurchaseCommon Stock | 2,005 | $24.89 | $49,904.45 |
DisclosureSEC source: 0001194412-03-000011 · c0001194412d20030506f4f.xml · nonDerivative · entry 1 FERDINANDI V MICHAEL · CIK 0001194412 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,024 F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.